Malachi Griffith

25.6k total citations · 4 hit papers
100 papers, 6.5k citations indexed

About

Malachi Griffith is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Malachi Griffith has authored 100 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 32 papers in Cancer Research and 28 papers in Immunology. Recurrent topics in Malachi Griffith's work include Cancer Genomics and Diagnostics (25 papers), Immunotherapy and Immune Responses (16 papers) and vaccines and immunoinformatics approaches (13 papers). Malachi Griffith is often cited by papers focused on Cancer Genomics and Diagnostics (25 papers), Immunotherapy and Immune Responses (16 papers) and vaccines and immunoinformatics approaches (13 papers). Malachi Griffith collaborates with scholars based in United States, Canada and Switzerland. Malachi Griffith's co-authors include Obi L. Griffith, Alex H. Wagner, Marco A. Marra, Elaine R. Mardis, Adam Coffman, Kelsy C. Cotto, Susanna Kiwala, Martin Hirst, Joshua F. McMichael and Allen Delaney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Malachi Griffith

92 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

2008 874 citations Malachi Griffith, Allen Delaney et al. profile →
Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts

2020 580 citations Susanna Kiwala, Kelsy C. Cotto et al. Nucleic Acids Research profile →
DGIdb 3.0: a redesign and expansion of the drug–gene interaction database

2017 551 citations Kelsy C. Cotto, Alex H. Wagner et al. Nucleic Acids Research profile →
DGIdb 5.0: rebuilding the drug–gene interaction database for precision medicine and drug discovery platforms

2023 142 citations Matthew Cannon, James Stevenson et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malachi Griffith United States	35	4.0k	2.2k	1.4k	1.2k	744	100	6.5k
Vladimir Lazar France	46	4.1k 1.0×	2.1k 0.9×	2.1k 1.5×	974 0.8×	954 1.3×	133	7.4k
Henry Yang Singapore	48	5.9k 1.5×	2.1k 0.9×	1.5k 1.1×	1.6k 1.4×	530 0.7×	168	8.7k
Qianxing Mo United States	39	3.2k 0.8×	1.0k 0.5×	1.8k 1.3×	845 0.7×	933 1.3×	138	6.2k
Ramana V. Davuluri United States	52	7.0k 1.7×	3.2k 1.4×	1.2k 0.9×	840 0.7×	521 0.7×	120	9.6k
Trevor J. Pugh Canada	34	2.8k 0.7×	1.3k 0.6×	1.4k 1.0×	857 0.7×	700 0.9×	149	5.0k
Robert G. Ramsay Australia	50	3.6k 0.9×	939 0.4×	2.1k 1.5×	934 0.8×	457 0.6×	176	6.5k
Chet Birger United States	2	4.1k 1.0×	1.9k 0.9×	1.7k 1.2×	1.5k 1.3×	1.6k 2.1×	3	7.1k
Obi L. Griffith United States	40	4.0k 1.0×	1.4k 0.7×	1.4k 1.0×	1.1k 0.9×	732 1.0×	112	6.6k
Domenico Delia Italy	43	4.2k 1.0×	1.2k 0.5×	2.5k 1.8×	950 0.8×	462 0.6×	125	6.9k
Peter Van Loo United Kingdom	35	4.1k 1.0×	2.9k 1.3×	1.8k 1.3×	521 0.5×	887 1.2×	83	7.0k

Countries citing papers authored by Malachi Griffith

Since Specialization

Citations

This map shows the geographic impact of Malachi Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malachi Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malachi Griffith more than expected).

Fields of papers citing papers by Malachi Griffith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malachi Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malachi Griffith. The network helps show where Malachi Griffith may publish in the future.

Co-authorship network of co-authors of Malachi Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of Malachi Griffith. A scholar is included among the top collaborators of Malachi Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malachi Griffith. Malachi Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griffith, Malachi, et al.. (2025). Identifying genetic errors of immunity due to mosaicism. The Journal of Experimental Medicine. 222(5). 2 indexed citations

Gomez, Felicia, Arpad Danos, Guilherme Del Fiol, et al.. (2024). A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. Cancer Discovery. 14(10). 1774–1778.

Skidmore, Zachary L., Hans Rindt, Shirley Chu, et al.. (2024). Single-cell T-cell receptor repertoire profiling in dogs. Communications Biology. 7(1). 484–484. 3 indexed citations

Cannon, Matthew, James Stevenson, Adam Coffman, et al.. (2023). DGIdb 5.0: rebuilding the drug–gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Research. 52(D1). D1227–D1235. 142 indexed citations breakdown →

Cannon, Matthew, James Stevenson, Kori Kuzma, et al.. (2023). Normalization of drug and therapeutic concepts with Thera-Py. JAMIA Open. 6(4). ooad093–ooad093. 1 indexed citations

Watkins, Marcus P., Todd A. Fehniger, Malachi Griffith, et al.. (2023). Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report. JCO Precision Oncology. 7(7). e2300177–e2300177. 1 indexed citations

Church, Alanna J., Shruti Rao, Arpad Danos, et al.. (2022). Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions. Cancer Genetics. 264-265. 50–59. 6 indexed citations

Rockwell, Nathan, Wei Yang, Nicole M. Warrington, et al.. (2021). Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis. Cancer Research Communications. 1(3). 148–163. 10 indexed citations

Mudianto, Tenny, Katie M. Campbell, Jason A. Webb, et al.. (2021). Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas. Clinical Cancer Research. 27(8). 2326–2339. 18 indexed citations

10.

Wagner, Alex H., Susanna Kiwala, Adam Coffman, et al.. (2020). CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase. JCO Clinical Cancer Informatics. 4(4). 245–253. 4 indexed citations

11.

Hundal, Jasreet, Susanna Kiwala, Joshua F. McMichael, et al.. (2020). pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens. Cancer Immunology Research. 8(3). 409–420. 145 indexed citations

12.

Popli, Pooja, Megan M. Richters, Sangappa B. Chadchan, et al.. (2020). Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation. Cell Death and Disease. 11(10). 842–842. 39 indexed citations

13.

Barnell, Erica K., Adam Waalkes, Kelsi Penewit, et al.. (2019). Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. JCO Clinical Cancer Informatics. 3(3). 1–12. 6 indexed citations

14.

Richters, Megan M., Huiming Xia, Katie M. Campbell, et al.. (2019). Best practices for bioinformatic characterization of neoantigens for clinical utility. Genome Medicine. 11(1). 56–56. 143 indexed citations

15.

Ainscough, Benjamin J., Erica K. Barnell, Peter Ronning, et al.. (2018). A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nature Genetics. 50(12). 1735–1743. 50 indexed citations

16.

Bartlett, Nancy L., Brian A. Costello, Betsy LaPlant, et al.. (2017). Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. Blood. 131(2). 182–190. 110 indexed citations

17.

Skidmore, Zachary L., Alex H. Wagner, Robert Lesurf, et al.. (2016). GenVisR: Genomic Visualizations in R. Bioinformatics. 32(19). 3012–3014. 209 indexed citations

18.

Krysiak, Kilannin, Felicia Gomez, Brian S. White, et al.. (2016). Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 129(4). 473–483. 110 indexed citations

19.

Cynthia, X., Jingqin Luo, Michael Naughton, et al.. (2015). A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 22(7). 1583–1591. 77 indexed citations

20.

Tucker, Tracy, Farah Zahir, Malachi Griffith, et al.. (2013). Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes. European Journal of Human Genetics. 22(6). 792–800. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact